Table of Contents
Metal-Based Drugs
Volume 3, Issue 5, Pages 243-260
http://dx.doi.org/10.1155/MBD.1996.243

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III)

Institute of Inorganic Chemistry, University of Heidelberg, Im Neuenheimer Feld 270, Heidelberg D-69120, Germany

Received 22 September 1996; Accepted 24 September 1996

Copyright © 1996 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kari-Georg Lipponer, Ellen Vogel, and Bernhard K. Keppler, “Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III),” Metal-Based Drugs, vol. 3, no. 5, pp. 243-260, 1996. https://doi.org/10.1155/MBD.1996.243.